Aktuellt
SENASTE
With phase 2 topline data expected to read out in the next few months, it will be worth watching FluoGuide carefully because our impression is that market expectations are not as high as our own. We anticipate getting a sense of the predictive value of FG001 in glioma surgery, which we believe will be strong, given what has already been announced.
LÄS MER
